Literature DB >> 9299362

Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.

C Weinbrenner1, G S Liu, M V Cohen, J M Downey.   

Abstract

p38 mitogen-activated protein kinase (MAPK) is known to be activated after exposure to endotoxin, osmotic and environmental stress, and, most recently, during ischemia/reperfusion. We investigated whether ischemic preconditioning also causes phosphorylation of the activation sites on p38 MAPK. Three groups of isolated rabbit hearts were studied. Control hearts experienced 30 min of ischemia only. The second group was preconditioned with 5 min of global ischemia and 10 min of reperfusion. Group 3 was also ischemically preconditioned, but in the presence of 100 microM 8-(p-sulfophenyl)theophylline (SPT). Transmural left ventricular biopsies were taken before and during the long ischemic period. Western blot analysis with either p38 MAPK or phospho-specific p38 MAPK (Tyr-182) antibodies showed a decreased phosphorylation during ischemia in non-preconditioned hearts, but phosphorylation was enhanced several fold after 10 and 20 min of ischemia in preconditioned hearts. Furthermore, when protection from ischemic preconditioning was blocked by SPT, increased phosphorylation of p38 MAPK during ischemia was not present. Therefore the phosphorylation of p38 MAPK at tyrosine 182, which is required for the kinase's activation, occurred during ischemia only when protection from preconditioning was evident. In a second study, changes in osmotic fragility were measured during simulated ischemia in rabbit cardiomyocytes. Reduced fragility in ischemically preconditioned myocytes could be completely abolished by the specific p38 MAPK inhibitor SB-203580. In contrast, anisomycin, an activator of p38 MAPK and JUN kinase pathways, was found to be as protective as ischemic preconditioning. We conclude that p38 MAPK phosphorylation correlates with preconditioning's protection, and that its activation may be an important step in the signal transduction cascade of ischemic preconditioning. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9299362     DOI: 10.1006/jmcc.1997.0473

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  40 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

2.  Enhanced estradiol-induced vasorelaxation in aortas from type 2 diabetic mice may reflect a compensatory role of p38 MAPK-mediated eNOS activation.

Authors:  Kumiko Taguchi; Akitaka Morishige; Takayuki Matsumoto; Katsuo Kamata; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2012-06-23       Impact factor: 3.657

3.  Bone morphogenic protein-7 contributes to cerebral ischemic preconditioning induced-ischemic tolerance by activating p38 mitogen-activated protein kinase signaling pathway.

Authors:  Junhong Guan; Han Li; Tao Lv; Duo Chen; Ye Yuan; Shengtao Qu
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

Review 4.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

5.  Protective effect of miR-20a against hypoxia/reoxygenation treatment on cardiomyocytes cell viability and cell apoptosis by targeting TLR4 and inhibiting p38 MAPK/JNK signaling.

Authors:  Xin-Yu Gong; Yun Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-23       Impact factor: 2.416

6.  Endothelin-1 activates p38 mitogen-activated protein kinase via endothelin-A receptor in rat myocardial cells.

Authors:  T Ueyama; S Kawashima; T Sakoda; Y Rikitake; T Ishida; M Kawai; M Namiki; M Yokoyama
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

7.  Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat.

Authors:  Ai-Hong Meng; Yi-Ling Ling; Xiao-Peng Zhang; Jun-Lan Zhang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 8.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

9.  Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.

Authors:  Jennifer L Strande; Michael E Widlansky; Nikos E Tsopanoglou; Jidong Su; JingLi Wang; Anna Hsu; Kasi V Routhu; John E Baker
Journal:  Cardiovasc Res       Date:  2009-04-20       Impact factor: 10.787

10.  Effect of p38 MAP kinases on contractility and ischemic injury in intact heart.

Authors:  H R Cross; M Li; B G Petrich; E Murphy; Y Wang; Charles Steenbergen
Journal:  Acta Physiol Hung       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.